A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Scientists at the Institute of Chemistry have developed a new type of contrast agent for magnetic resonance imaging (MRI)—bovine serum albumin nanoparticles doped with manganese (II) ions. The results ...

A research team from IOCB Prague, working in collaboration with the University of Tübingen, Germany, and the Faculty of Science, Charles University, has developed a new type of contrast agent that can ...

MRI contrast agents, which are typically gadolinium-based, are used to enhance visualization of abnormal structures or lesions and to aid differentiation between healthy and pathological tissue. This ...

The Contrast Media Market is expected to experience a steady growth rate of 5-6% CAGR. Key drivers of this growth include ...

New research suggests that MRI with contrast may create nanoparticles that infiltrate your tissues. The research is preliminary, and more work needs to be done. Doctors stress that MRI with contrast ...

Compared to group I GBCAs, group II GBCAs appear safe for use in patients with severe kidney disease. In a recent analysis, the risk of NSF in patients with stage 4 or 5 CKD was less than 0.07% with ...

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels. A team formed by the ...

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...